Brussels, Belgium

Lindsay Devolder

This inventor holds 1 USPTO granted patent. Top assignees: Katholieke Universiteit Leuven, Vib Vzw, Vrije Universiteit Brussel. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lindsay Devolder. Retrieved from https://idiyas.com/inventor/lindsay-devolder

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lindsay Devolder: Innovator in Gut Inflammation Research

Introduction

Lindsay Devolder is a notable inventor based in Brussels, Belgium. She has made significant contributions to the field of inflammation-associated disorders, particularly focusing on gut inflammation. Her innovative work has led to the development of methods aimed at diagnosing and treating these conditions.

Latest Patents

Lindsay Devolder holds 1 patent titled "Inflammation associated, low cell count enterotype." This invention relates to the diagnosis and treatment of inflammation-associated disorders or conditions. The methods provided in her patent aim to reduce the severity of gut inflammation in subjects in need.

Career Highlights

Throughout her career, Lindsay has worked with reputable organizations such as Vib Vzw and Katholieke Universiteit Leuven, also known as KU Leuven R&D. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Lindsay has collaborated with esteemed colleagues, including Jeroen Raes and Gwen Falony. These partnerships have enriched her research and expanded the impact of her work in the field of inflammation.

Conclusion

Lindsay Devolder's innovative contributions to gut inflammation research highlight her role as a significant inventor in the medical field. Her patent and collaborations reflect her commitment to advancing the understanding and treatment of inflammation-associated disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…